Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...
The mission of Pratt Institute’s Human Research Subjects Committee / Institutional Review Board (IRB) is to ensure quality research involving human subjects conducted under the auspices of the ...
Following Phase 3 trials, the drug candidate manufacturer can apply for a New Drug Application (NDA) from the FDA. The FDA ...
Leaders across higher education and industry must ensure that their teams and partners think critically about anonymization, informed consent and data handling.
All human subjects research connected with members of the Smith College community (either as researchers or study participants) must be reviewed and approved by the IRB prior to the initiation of the ...
Pritchard worked in the Office for Human Research Protections for 20 years and retired as the senior adviser to the director of OHRP in 2024. Deciding whether to participate in a clinical research ...